- Advanced search
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|Approved drug?||Yes (source: FDA (1993))|
|International Nonproprietary Names|
|CAS Registry No.||81098-60-4 (source: Scifinder)|
|Search Google for chemical match using the InChIKey||DCSUBABJRXZOMT-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||DCSUBABJRXZOMT|
|Search PubMed clinical trials||cisapride|
|Search PubMed titles||cisapride|
|Search PubMed titles/abstracts||cisapride|
|Cisapride is an enantioneric mixture and we show the non-stereoisomeric structure here to represent the mixture. One stereoisomeric structure is shown by CHEMBL560739.
Cisapride must be used with caution due to reports of drug-induced arrhythmias and long QT syndrome. Although this drug was originally given marketing approval by the US FDA in 1993, all registered formulations have since been discontinued. In the EU (since 2002) conditions of use have been applied to active marketing authorisations for cisapride containing medicinal products.